On October 26 and 27, the representative of HM&P Law Firm ("HM&P"), Managing Partner Nguyen Van Phuc, participated in a series of important pharmaceutical industry conferences organized by the Ministry of Health in Da Nang City, including: Dialogue Conference between the Ministry of Health and Pharmaceutical Companies (originally held on October 26); Conference to Collect Comments on the Law Project to Amend and Supplement a Number of Articles of the Law on Pharmacy (morning of October 27); Briefing on Pharmaceuticals, Cosmetics and Digital Transformation in the Pharmaceutical Sector in 2023 (afternoon of October 27).
The conference program included many important and noteworthy contents not only for the pharmaceutical industry, but also very useful for pharmaceutical industry consultants such as HM&P.
Dialogue conference between the Ministry of Health and pharmaceutical companies
View at the dialogue conference between the Ministry of Health and Pharmaceutical Companies
On October 26, the Dialogue Conference between the Ministry of Health and Pharmaceutical Companies was held under the chairmanship of Mr. Do Xuan Tuyen, Deputy Minister of Health, with the participation of Mr. Ho Ky Minh, Member of the Standing Committee, Standing Vice Chairman of Da Nang People's Committee; ASS. TS. Le Van Truyen - Chairman of the Advisory Council for Issuing Registration Certificates for Distribution of Drugs and Medicinal Raw Materials, former Deputy Minister of Health; representatives of relevant departments, divisions and branches and hundreds of enterprises and associations in the pharmaceutical field throughout the country.
At this dialogue, for the second time (in 2023), the Ministry of Health, especially the Drug Administration of Vietnam, frankly exchanged openly with the business community to listen and resolve, difficulties and obstacles that enterprises encounter not only about administrative procedures, the delay in resolving these procedures, but the Drug Administration also discussed policies and mechanisms to solve these shortcomings in the coming period with the highest sense of responsibility of pharmaceutical management agencies.
Deputy Minister of Health Do Xuan Tuyen spoke at the dialogue conference between the Ministry of Health and Pharmaceutical Companies. Source: https://moh.gov.vn/
In addition, at the conference, Deputy Minister of Health Do Xuan Tuyen also stressed that in order to promote rapid and sustainable development of enterprises, the Ministry of Health has been gradually focusing on promoting the reform of administrative procedures, improving the business investment environment, removing difficulties, etc. solve bottlenecks, shortcomings in policy mechanisms ... in particular, the development and promulgation of legal documents for the Ministry of Health to study and consider, in order to provide specific solutions to promptly remove difficulties and obstacles, create a favorable business investment environment for enterprises in the coming period.
Managing Partner Nguyen Van Phuc at the dialogue conference between the Ministry of Health and Pharmaceutical Companies
Attending the conference, Managing Partner Nguyen Van Phuc, representing some clients of HM&P as well as the role of consultants, also made speeches and suggested that the Drug Administration should pay attention and adjust administrative procedures for pharmaceutical enterprises to be accelerated in accordance with the law in the coming period.
The Conference collected opinions on the draft law amending and supplementing some articles of the Law on Pharmacy
View of The Conference collected opinions on the draft law amending and supplementing some articles of the Law on Pharmacy
On the morning of October 27, Mr. Do Xuan Tuyen, Deputy Minister of Health, continued to chair the conference to collect comments on the draft law amending and supplementing a number of articles of the Law on Pharmacy. The conference was attended by nearly 1,000 delegates from central agencies and ministries, WHO, international organizations, local health departments; domestic and international pharmaceutical industry.
The draft law, which amends and supplements a number of articles of the Law on Pharmacy, will be submitted to the National Assembly for comments at the 7th session (5 May 2024) and to the National Assembly for approval at the 8th session (October 2024).
Some proposals at The Conference collected opinions on the draft law amending and supplementing some articles of the Law on Pharmacy
Mr. Vu Tuan Cuong, Director General of the Drug Administration of Vietnam, said that the project to amend and supplement the Pharmaceutical Law will amend and supplement 38 articles of the Pharmaceutical Law of 2016; in particular, 36 articles will be amended, 2 articles will be supplemented, and 1 article will be abolished.
At the Conference, delegates discussed, made important opinions and closely followed the actual content of the industry's activities. Specifically, the delegates who are pharmaceutical enterprises demanded: expand the business activities of foreign-invested pharmaceutical enterprises, build corridors to apply e-commerce in the pharmaceutical industry, improve drug circulation registration procedures,....
Managing Partner Nguyen Van Phuc at The Conference collected opinions on the draft law amending and supplementing some articles of the Law on Pharmacy
As a law firm specializing in consulting in the field of pharmaceuticals and cosmetics, representatives of HM&P also commented on the need to expand the investment field of foreign investors in the pharmaceutical sector, but also need to consider the protection of young pharmaceutical enterprises in the country. In addition, the application of e-commerce in the pharmaceutical business is necessary, and in line with the development trend, the relevant authorities need to be careful when creating a legal corridor for this activity.
The drafting committee of the Ministry of Health listened to the delegates' important suggestions and discussed them, which will be considered and adjusted in the upcoming draft to the National Assembly.
Briefing Conference Summarizing the Activities of the Drug Administration
View of the Briefing Conference Summarizing the Activities of the Drug Administration
In the afternoon of October 27, the Ministry of Health and the Drug Administration released a report summarizing the activities of the first 10 months of the year. At the same time, the Ministry of Health and the Drug Administration exchanged information on plans and strategies for the development of the pharmaceutical industry in the coming period.
And another part of the agenda, at this meeting, the Ministry of Health as well as delegates had presentations and exchanges on digital transformation in the pharmaceutical industry. One thing that the Ministry of Health, especially the Drug Administration, is doing well, but there are still steps to improve and adjust in the near future.
Managing Partner Nguyen Van Phuc took a souvenir photo with Deputy Minister of Health Do Xuan Tuyen
At these important pharmaceutical industry conferences, Mr. Nguyen Van Phuc, the Managing Partner, and representative of HM&P, had the opportunity to listen and discuss with pharmaceutical enterprises in Vietnam on the difficulties and challenges they may face in order to contribute ideas to the project of the amended law, to add a number of articles to the Pharmacy Law. At the same time, we can listen to the operation report of the Ministry of Health and Drug Administration in the first ten months of the year and the operation plan and development direction of the pharmaceutical industry in 2024.
Managing Partner Nguyen Van Phuc at the Briefing Conference Summarizing the Activities of the Drug Administration
This is a great opportunity for a law firm practice in pharmaceutical and cosmetic field like HM&P to meet clients and partners in the industry. It is also an opportunity to exchange and consult with experts and industry management agencies such as the Drug Administration of Vietnam. The pharmaceutical industry conferences in Da Nang City ended successfully. HM&P representatives also had a valuable time to listen to enterprises and relevant agencies in the pharmaceutical industry to gain more experience and knowledge to provide better legal services to pharmaceutical enterprises in the future.
